Pharvaris NV (PHVS)

전일 마감가:

$21.71

열려 있는:

$21.7

하루 거래량:

33,049

시가총액:

$1.10B

수익:

-

순이익/손실:

$-84.47M

주가수익비율:

-9.5182

EPS:

-2.138

순현금흐름:

$-100.83M

1주 성능:

-5.17%

1개월 성능:

-4.01%

6개월 성능:

+26.01%

1년 성능:

+139.41%

1일 변동 폭

$19.53

$21.70

52주 변동 폭

$8.20

$33.00

Pharvaris NV Stock (PHVS) Company Profile

명칭

Pharvaris NV

부문

Healthcare (1209)

산업

Biotechnology (699)

전화

31 71 203 6410

주소

J.H. Oortweg 21, Leiden

직원

0

트위터

다음 수익 날짜

2024-05-16

최신 SEC 제출 서류

PHVS's Discussions on Twitter

Pharvaris NV Stock (PHVS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-09-25	개시	Wedbush	Outperform
2023-08-15	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2022-10-05	개시	Bryan Garnier	Buy
2022-09-13	재개	JMP Securities	Mkt Outperform
2022-08-23	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2022-08-22	다운그레이드	BofA Securities	Neutral → Underperform
2022-05-25	개시	JMP Securities	Mkt Outperform
2021-03-02	개시	BofA Securities	Neutral
2021-03-02	개시	Morgan Stanley	Overweight
2021-03-02	개시	Oppenheimer	Outperform
2021-03-02	개시	SVB Leerink	Outperform

모두보기

Pharvaris NV 주식(PHVS)의 최신 뉴스

Morgan Stanley Reiterates Pharvaris (PHVS) Equal-Weight Recommendation - MSN

MSN

Objective long/short (PHVS) Report - Stock Traders Daily

Stock Traders Daily

Pharvaris (NASDAQ:PHVS) Price Target Lowered to $31.00 at Wedbush - Defense World

Defense World

Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses - WDRB

WDRB

Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses

GlobeNewswire Inc.

Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update - br.ADVFN.com

br.ADVFN.com

Pharvaris NV (PHVS) 재무 분석

Pharvaris NV (PHVS) 순이익 2024

Pharvaris NV (PHVS) 현금흐름 2024

Pharvaris NV (PHVS) 주당 순이익 2024